The eye is the specialized part of the body and is comprised of numerous physiological
ocular barriers that limit the drug absorption at the action site. Regardless of various efforts …

Nanoemulsions formulated for the ocular drug delivery have a good scope in
pharmaceutical products due to the transparency at enlarged droplet volume fraction …

Nanoemulsions are liquid-in-liquid dispersion with a droplet size of about 100 nm. They
have a transparent appearance, high rate of bioavailability, and increased shelf life …

Nanoemulsions are considered as the most promising solution to improve the delivery of
ophthalmic drugs. The design of ophthalmic nanoemulsions requires an extensive …

Sufficient ophthalmic drug delivery is still challenging for pharmaceutical technologists,
despite various scientific efforts. Several ocular drug carriers have been designed to …

Despite numerous scientific efforts, efficient ocular drug delivery remains a challenge for
pharmaceutical scientists. Most ocular diseases are treated by topical drug application in the …

Application of a drug in the form of eye drops represents easiest, safest and, at the moment,
the most common non-invasive method of ocular drug application. Other conventional …

Topical ophthalmic delivery of active ingredients can be achieved using cationic
nanoemulsions. In the last decade, Novagali Pharma has successfully developed and …

Diseases affecting the anterior segment of the eye are the primary causes of vision
impairment and blindness globally. Drug administration through the topical ocular route is …

Eye drops are the most accessible therapy for ocular diseases, while inevitably suffering
from their lower bioavailability which highly restricts the treatment efficacy. The introduction …